Ixabepilone + Capecitabine
CA163-046
Phase 3 small_molecule completed
Quick answer
Ixabepilone + Capecitabine for Breast Cancer is a Phase 3 program (small_molecule) at Semnur Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Semnur Pharmaceuticals
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed